不幸从来不是单独发生的:微生物代谢物将心力衰竭和慢性病联系起来
Jingyuan Fu1, Nine V A M Knoers2
1Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Cell host & microbe
|October 9, 2025
概括
在慢性病患者中,产生毒素的大肠杆菌可导致心力衰竭. 在动物模型和人体试验中,发现益生菌干预可以降低这种风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 微生物学 微生物学
背景情况:
- 心力衰竭是慢性病 (CKD) 患者中普遍存在的严重疾病.
- 慢性脏病和心力衰竭之间的联系是复杂的和多因素的.
- 在CKD中导致心力衰竭的特定分子机制需要进一步阐明.
研究的目的:
- 调查大肠杆菌 (大肠杆菌) 酸盐代谢在患有功能障碍的患者心力衰竭的发病过程中的作用.
- 评估特定益生菌产品在减轻与CKD相关的心力衰竭风险方面的有效性.
主要方法:
- 这项研究研究了产生毒素的大肠杆菌酸盐代谢对心肌亡的影响.
- 使用临床前模型来评估益生菌干预的效果.
- 进行了临床试验,以验证在人类受试者身上发现的结果.
主要成果:
- 产生毒素的大肠杆菌托芬代谢被确定为心肌亡的显著诱导因子.
- 这一过程在功能障碍的背景下增加了心力衰竭的风险.
- 测试中的益生菌产品在临床前和临床环境中都证明了心力衰竭风险的降低.
结论:
- 在慢性病患者心力衰竭的发展中,大肠杆菌的酸盐代谢起着至关重要的作用.
- 益生菌干预代表了一个潜在的治疗策略,以减少心力衰竭的风险在这个脆弱的人群.
- 对肠--心轴的进一步研究是有必要的,以探索新的治疗途径.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
552
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
552
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Heart Failure Drugs: Diuretics
804
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
804
Chronic Kidney Disease I: Introduction
560
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
560
Chronic Kidney Disease III: Interprofessional Care
339
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722


